Search research articles
Contact Us
Filters
Showing results (431-440 of 628) with videos related to
Page
of 63
Sort By:
Proceedings of the ... IEEE Conference on Nanotechnology. IEEE Conference on Nanotechnology
|
June 21, 2014
Testing in EHS: What is the Current Status of Experimentation?
Donald R Baer, Ajay S Karakoti, Prabhakaran Munusamy, et al.
Leukemia & Lymphoma
|
July 25, 2014
A novel TTC40-MSI2 fusion in de novo acute myeloid leukemia with an unbalanced 10;17 translocation
Reza Saleki, Todd Christensen, Weihua Liu, et al.
Molecular Cancer Therapeutics
|
February 11, 2021
PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition-Dependent GSK-3β-Mediated c-Myc and Pim-1 Proteasomal Degradation
Mario Scarpa, Prerna Singh, Christopher M Bailey, et al.
Leukemia Research
|
July 20, 2018
Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms
J Berdeja, F Palandri, M R Baer, et al.
Nature Genetics
|
December 1, 1996
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
L C Wu, Z W Wang, J T Tsan, et al.
International Journal of Molecular Epidemiology and Genetics
|
September 28, 2011
XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia
Nataliya Kuptsova-Clarkson, Christine B Ambrosone, Joli Weiss, et al.
Cancer
|
April 2, 2011
Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia
Meir Wetzler, Chris Andrews, Laurie A Ford, et al.
Clinical Therapeutics
|
October 9, 2017
Enrollment of Neonates in More Than One Clinical Trial
Jonathan M Davis, Gerri R Baer, Ronald Portman, et al.
Annals of Hematology
|
September 22, 2011
Is obesity a prognostic factor for acute myeloid leukemia outcome?
Hun Ju Lee, Andrea S Licht, Andrew J Hyland, et al.
Cancer Chemotherapy and Pharmacology
|
March 7, 2021
Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens
Sarah M Kashanian, Noa G Holtzman, Ciera L Patzke, et al.
Page
of 63
Search research articles
Search
Showing results (431-440 of 628) with videos related to
Sort By:
Page
of 63
Proceedings of the ... IEEE Conference on Nanotechnology. IEEE Conference on Nanotechnology
|
June 21, 2014
Testing in EHS: What is the Current Status of Experimentation?
Donald R Baer, Ajay S Karakoti, Prabhakaran Munusamy, et al.
Leukemia & Lymphoma
|
July 25, 2014
A novel TTC40-MSI2 fusion in de novo acute myeloid leukemia with an unbalanced 10;17 translocation
Reza Saleki, Todd Christensen, Weihua Liu, et al.
Molecular Cancer Therapeutics
|
February 11, 2021
PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition-Dependent GSK-3β-Mediated c-Myc and Pim-1 Proteasomal Degradation
Mario Scarpa, Prerna Singh, Christopher M Bailey, et al.
Leukemia Research
|
July 20, 2018
Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms
J Berdeja, F Palandri, M R Baer, et al.
Nature Genetics
|
December 1, 1996
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
L C Wu, Z W Wang, J T Tsan, et al.
International Journal of Molecular Epidemiology and Genetics
|
September 28, 2011
XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia
Nataliya Kuptsova-Clarkson, Christine B Ambrosone, Joli Weiss, et al.
Cancer
|
April 2, 2011
Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia
Meir Wetzler, Chris Andrews, Laurie A Ford, et al.
Clinical Therapeutics
|
October 9, 2017
Enrollment of Neonates in More Than One Clinical Trial
Jonathan M Davis, Gerri R Baer, Ronald Portman, et al.
Annals of Hematology
|
September 22, 2011
Is obesity a prognostic factor for acute myeloid leukemia outcome?
Hun Ju Lee, Andrea S Licht, Andrew J Hyland, et al.
Cancer Chemotherapy and Pharmacology
|
March 7, 2021
Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens
Sarah M Kashanian, Noa G Holtzman, Ciera L Patzke, et al.
Page
of 63